Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

CTP Develops New Sustainable Production Facility for SCHOTT Pharma at CTPark Jagodina, Expanding Global Manufacturing Network

(IN BRIEF) CTP has successfully developed a state-of-the-art 18,000 sqm production facility for SCHOTT Pharma at CTPark Jagodina, Serbia, where high-quality glass ampoules for vaccines and medications will be produced. This facility is a significant addition to SCHOTT Pharma’s global … Read the full press release

University of Copenhagen Researchers Unveil Biosynthetic Method to Cut the Cost of Taxol and Make Production More Sustainable

(IN BRIEF) Researchers from the University of Copenhagen have made a breakthrough in the biosynthetic production of Taxol, a widely used chemotherapy drug. By identifying the enzymes responsible for the final steps in the biosynthetic pathway of Taxol, the team … Read the full press release

SAF Tehnika Combines Wellness and Innovation through Weekly Training Runs, Building Team Spirit and Employee Growth

(IN BRIEF) SAF Tehnika has created a unique company culture by incorporating weekly joint training run sessions, where employees from all departments unite to challenge themselves both physically and mentally. What started as a wellness initiative has grown into a … Read the full press release

OptiSigns anuncia su expansión Europea

OptiSigns ha abierto una nueva oficina en Munich, Alemania y ha añadido liderazgo clave para apoyar mejor a los clientes de la UE OptiSigns es una empresa líder en señalización digital en Norteamérica, con más de 30.500 clientes en 121 … Read the full press release

OptiSigns annonce son expansion européenne

OptiSigns a ouvert un nouveau bureau à Munich, en Allemagne, et a recruté des dirigeants clés pour mieux soutenir les clients de l’UE OptiSigns est la principale entreprise de signalisation numérique en Amérique du Nord, avec plus de 30 500 … Read the full press release

OptiSigns kündigt europäische Expansion an

OptiSigns hat ein neues Büro in München, Deutschland eröffnet und Führungskräfte hinzugefügt, um EU-Kunden besser zu unterstützen OptiSigns ist das führende Digital-Signage-Unternehmen in Nordamerika mit über 30.500 Kunden in 121 Ländern, die ihre Hardware und Software zur Anzeige von Beschilderungen … Read the full press release

OptiSigns Announces European Expansion

OptiSigns has opened a new office in Munich, Germany and added key leadership to better support EU customers OptiSigns is the leading digital signage company in North America, with over 30,500 customers in 121 countries using their hardware and software … Read the full press release

AstraZeneca’s Imfinzi Plus BCG Induction and Maintenance Therapy Significantly Improves Disease-Free Survival in High-Risk Non-Muscle-Invasive Bladder Cancer

(IN BRIEF) The POTOMAC Phase III trial results show that adding Imfinzi to standard BCG induction and maintenance therapy improves disease-free survival (DFS) for patients with high-risk non-muscle-invasive bladder cancer (NMIBC). The combination demonstrated significant benefits over BCG alone, with … Read the full press release

Aviva’s Group Income Protection Helps Over 2,600 Employees Return to Work in 2024

(IN BRIEF) Aviva’s 2024 Group Protection Claims and Wellbeing Insight Report reveals that over 2,600 employees received vocational rehabilitation support, with 86% returning to work. The report highlights mental health, cancer, and musculoskeletal claims as key focus areas, with a … Read the full press release

University of York Researchers Secure £4.5 Million Wellcome Discovery Award to Expand Born in Bradford Study

(IN BRIEF) The University of York’s team has secured a £4.5 million Wellcome Discovery Award to extend the Born in Bradford research programme, which will now study 8,000 children and their families in Bradford. Building on the success of the … Read the full press release

University of Cambridge and NHS Digital Study Reveals Key Differences in Social Media Use Among Adolescents with Mental Health Conditions

(IN BRIEF) A new study from the University of Cambridge has revealed that adolescents with mental health conditions, particularly those with anxiety and depression, use social media differently than their peers. The research shows that these young people spend more … Read the full press release

Heart Failure 2025: Global Congress in Belgrade to Showcase the Latest Advancements in Heart Failure Treatment and Research

(IN BRIEF) Heart Failure 2025, organized by the Heart Failure Association (HFA) of the European Society of Cardiology, will take place in Belgrade, Serbia, from May 17 to 20, 2025. The congress will feature over 80 scientific sessions, including Late-Breaking … Read the full press release

Fraunhofer Researchers Develop Advanced Cardiac Organoid to Evaluate Drug Safety and Prevent Cardiovascular Side Effects

(IN BRIEF) Researchers at the Fraunhofer Institute for Toxicology and Experimental Medicine and Hannover Medical School have developed an innovative cardiac organoid model that simulates a miniature, functional heart to test the cardiotoxicity of new medications. Comprising heart muscle cells, … Read the full press release

Fraunhofer IIS Innovates Sensor Technology to Prevent Fires in Recycling Plants Caused by Lithium-Ion Batteries

(IN BRIEF) To address the growing issue of battery fires in recycling plants, researchers at Fraunhofer IIS have developed a groundbreaking sorting system that uses X-ray technology and AI to detect hazardous lithium-ion batteries early in the recycling process. The … Read the full press release

Fraunhofer Researchers Develop Contactless Radar Sensor System for Non-Invasive Patient Monitoring

(IN BRIEF) Researchers at Fraunhofer IZM, in partnership with B-COS GmbH, are developing a mobile, low-power radar sensor system designed for non-contact patient monitoring. The system enables the measurement of heart and respiratory rates without the need for electrodes, offering … Read the full press release

Fraunhofer and B-COS Collaborate on Biodegradable Face Mask to Reduce Wrinkles and Stimulate Collagen Production

(IN BRIEF) Researchers from Fraunhofer TLC-RT and B-COS GmbH have created a biodegradable anti-aging face mask that stimulates collagen production through ortho-silicic acid, offering long-lasting wrinkle reduction. Unlike traditional face masks that only provide temporary hydration, this mask’s active ingredient, … Read the full press release

AstraZeneca’s Breztri Aerosphere Shows Positive Phase III Results for Uncontrolled Asthma Treatment

(IN BRIEF) Positive results from the Phase III KALOS and LOGOS trials show that AstraZeneca’s Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) significantly improves lung function in patients with uncontrolled asthma, compared to dual-combination ICS/LABA therapy. The trials demonstrate the potential of Breztri … Read the full press release

TUM Leads Telemedicine Pilot in Traunstein to Enhance Elder Care and Reduce Hospital Admissions

(IN BRIEF) The district of Traunstein is launching a new telemedicine project, led by the Technical University of Munich (TUM), to improve healthcare for elderly nursing home residents. The project uses a specially developed telemedicine kit that allows nursing staff … Read the full press release

University of Southampton Scientists Engineer Super-Strong Antibody to Boost Immune Response Against Cancer

(IN BRIEF) Scientists at the University of Southampton have engineered a new type of super-strong antibody, which could significantly enhance immune system responses in cancer patients. By altering the shape and rigidity of antibodies, the team discovered that these modified … Read the full press release

New FOxTROT 5 Trial by University of Glasgow, University of Leeds, and University of Birmingham Aims to Transform Colon Cancer Treatment for Elderly Patients with Promising Immunotherapy Approach

(IN BRIEF) The University of Glasgow is leading the innovative FOxTROT 5 trial, which is offering elderly colon cancer patients the opportunity to participate in a groundbreaking immunotherapy study. The trial will administer dostarlimab before surgery, targeting a specific type … Read the full press release